Guanfacine for Children with Tic Disorders

Conditions

Chronic Motor Tic Disorder | Chronic Vocal Tic Disorder | Tourette Syndrome

What is the purpose of this trial?

Does your child or teenager have a chronic vocal or motor tic disorder, such as Tourette’s? Yale Child Study Center is recruiting children and teens for a study with the new extended release form of guanfacine, called Intuniv®. The treatment targets involuntary actions or vocalizations (tics) in children with tic disorders, such as Tourette Syndrome.

Participation Guidelines

Age:
6 Years - 16 Years
Gender:
Both

Click here for detailed information about who can participate in this trial.


Sponsor:
Shire Pharmaceuticals
Dates:
March 2012 - September 2013
Last Updated:
Study HIC#:
1006004435